Downregulation of galectin-3 was demonstrated in inflamed intestinal mucosa of patients with inflammatory bowel disease, but elevated serum levels are present in patients with ulcerative colitis and Crohn’s disease [92,93]. Here, LGALS3 is linked to Crohn disease.